Free Trial

Aldeyra Therapeutics (ALDX) Earnings Date, Estimates & Call Transcripts

Aldeyra Therapeutics logo
$4.85 +0.04 (+0.83%)
(As of 11/22/2024 ET)

Aldeyra Therapeutics Latest Earnings Summary

Upcoming
Earnings Date
Mar. 6Estimated
Actual EPS
(Nov. 7)
-$0.25
Consensus EPS
(Nov. 7)
-$0.25

Aldeyra Therapeutics posted Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.25, which hit the consensus estimate of -$0.25. With a trailing EPS of $0.00, Aldeyra Therapeutics' earnings are expected to grow next year, from ($0.89) to ($0.16) per share.

ALDX Upcoming Earnings

Aldeyra Therapeutics' next earnings date is estimated for Thursday, March 6, 2025, based off prior year's reporting schedules.

Get Aldeyra Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aldeyra Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ALDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aldeyra Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.15$0.02-$0.07
Q2 20242-$0.15-$0.14-$0.15
Q3 20242-$0.19-$0.17-$0.18
Q4 20242-$0.28-$0.18-$0.23
FY 20248($0.77)($0.47)($0.62)

Aldeyra Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/6/2025
(Estimated)
------- 
11/7/2024--$0.25-$0.25--$0.25--
5/2/2024Q1 2024-$0.08-$0.14 -$0.06-$0.14--  
3/7/2024Q4 2023-$0.21-$0.08+$0.13-$0.08--  
11/3/2023Q3 2023--$0.14 -$0.14-$0.14--  
8/3/2023Q2 2023-$0.31-$0.15+$0.16-$0.15--  
5/4/2023Q1 2023-$0.30-$0.27+$0.03-$0.27--  
3/9/2023Q4 2022-$0.34-$0.22+$0.12-$0.22--    

Aldeyra Therapeutics Earnings - Frequently Asked Questions

Aldeyra Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates. Learn more on ALDX's earnings history.

In the previous quarter, Aldeyra Therapeutics (NASDAQ:ALDX) reported ($0.25) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.25). Learn more on analysts' earnings estimate vs. ALDX's actual earnings.

Aldeyra Therapeutics (NASDAQ:ALDX) has a recorded net income of -$37.54 million. ALDX has generated $0.00 earnings per share over the last four quarters.

Aldeyra Therapeutics's earnings are expected to grow from ($0.89) per share to ($0.16) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:ALDX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners